The health insurer also reported earnings that beat Wall Street’s expectations, a result that may calm investors worried about rising costs hitting health insurers’ results.
Biotechnology startups are seeking to improve a type of guided-missile treatment for cancer attracting increased interest from top pharmaceutical companies.
Japan likely carried out a second round of significant yen-buying intervention this week, according to a calculation based on data from the Bank of Japan and private money brokers.
Hong Kong’s economy lost steam at the start of the year, as consumer and government spending weakened, but export strength helped growth beat consensus views that had tipped a much sharper slowdown.
The check from Chubb would be the first large payout in what will likely be a yearslong wrangle over who bears the $1 billion-plus estimated cost of the bridge’s collapse.